Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

TNF-alpha-inhibitory thiazolopyrimidines patented by group at U. of California

Jan. 5, 2001

Chemokine inhibitors described by Teijin for rheumatoid arthritis and other disorders

Jan. 5, 2001

Compounds promoting proteoglycan production claimed by Sumitomo

Jan. 5, 2001

New glycopeptide antibiotics with improved profiles

Jan. 5, 2001

Recent patent covers MMP and TACE inhibitors from Fuji Yakuhin

Jan. 4, 2001

Therapeutically useful metalloproteinase inhibitors designed at Darwin Discovery

Jan. 4, 2001

New prodrugs synthesized by Sumitomo useful for neurodegenerative disorders

Jan. 4, 2001

Japanese lab discovers analgesic agents derived from coumarin

Jan. 4, 2001

Diphenylethylene and styrene derivatives useful for diabetes

Jan. 4, 2001

Use of (S)-oxybutynin for asthma claimed by Sepracor in recent patent

Jan. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...